Ansa Capital led a $15m Series A round in Synthpop.

Ansa Capital, a venture capital firm, led a $15m Series A round in Synthpop, a healthcare AI company that builds agentic automation to eliminate administrative bottlenecks in payer, provider, and patient operations, with participation from Ansa Capital, Defy.vc, Peterson Ventures, Storm Ventures, and Bruce Broussard. “Healthcare organizations have long been constrained by highly manual workflows and human capital bottlenecks. AI-native solutions like Synthpop are the only way for them to fulfill rising demand and increased patient expectations. The early value delivered to customers has been extremely compelling; I’m thrilled to join the Board and partner with Elad and the Synthpop team,” Marco DeMeireles, Ansa Co‑Founder and Managing Partner.